左旋多巴对帕金森病影响的定量评估。 - Suppr

Suppr

超能文献

A quantitative evaluation of the effects of L-dopa on Parkinson's disease.

作者信息

Velasco F, Velasco M

出版信息

Neuropharmacology. 1973 Feb;12(2):89-99. doi: 10.1016/0028-3908(73)90079-8.

DOI:10.1016/0028-3908(73)90079-8

PMID:4595553

Abstract

摘要

相似文献

A quantitative evaluation of the effects of L-dopa on Parkinson's disease.左旋多巴对帕金森病影响的定量评估。

Neuropharmacology. 1973 Feb;12(2):89-99. doi: 10.1016/0028-3908(73)90079-8.

[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].左旋多巴与脱羧酶抑制剂（苄丝肼，Ro 4-4602）联合治疗帕金森病的2年经验

Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.

[Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].

Minerva Med. 1974 May 2;65(33):1811-23.

[Treatment of Parkinson's disease with L-dopa. 77 cases].

Rev Neurol (Paris). 1970 Feb;122(2):89-102.

The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.

Confin Neurol. 1972;34(2):130-5.

A year's experience of L-DOPA in the treatment of Parkinson's disease.

Acta Neurochir (Wien). 1971;24(2):81-8. doi: 10.1007/BF01403313.

Effects of L-dopa on the H-reflex in parkinsonism.

J Am Geriatr Soc. 1971 Apr;19(4):289-95. doi: 10.1111/j.1532-5415.1971.tb05368.x.

Amantadine for Parkinson's disease.

Neurology. 1971 Sep;21(9):958-62. doi: 10.1212/wnl.21.9.958.

An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.对六名对左旋多巴治疗无反应的帕金森病患者的分析。

J Neurol Neurosurg Psychiatry. 1973 Jun;36(3):362-7. doi: 10.1136/jnnp.36.3.362.

A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa.

Arch Neurol. 1973 Aug;29(2):120-1. doi: 10.1001/archneur.1973.00490260064013.

引用本文的文献

Medication improves velocity, reaction time, and movement time but not amplitude or error during memory-guided reaching in Parkinson's disease.药物改善了帕金森病患者记忆引导性伸手过程中的速度、反应时间和运动时间，但不改善幅度或误差。

Physiol Rep. 2024 Sep;12(17):e16150. doi: 10.14814/phy2.16150.

Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's disease.在帕金森病患者视觉引导伸手动作过程中，药物仅能改善肢体运动，而深部脑刺激则能改善眼部和肢体运动。

Front Hum Neurosci. 2023 Oct 2;17:1224611. doi: 10.3389/fnhum.2023.1224611. eCollection 2023.

Quantifying upper limb motor impairment in people with Parkinson's disease: a physiological profiling approach.帕金森病患者上肢运动障碍的量化：一种生理特征分析方法。

PeerJ. 2021 Feb 5;9:e10735. doi: 10.7717/peerj.10735. eCollection 2021.

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.运动减少不明显可将进行性核上性麻痹与帕金森病区分开来。

Brain. 2012 Apr;135(Pt 4):1141-53. doi: 10.1093/brain/aws038. Epub 2012 Mar 6.

Characteristics of the sequence effect in Parkinson's disease.帕金森病中序列效应的特征。

Mov Disord. 2010 Oct 15;25(13):2148-55. doi: 10.1002/mds.23251.

Usefulness of movement time in the assessment of Parkinson's disease.

J Neurol. 1994 Aug;241(9):543-50. doi: 10.1007/BF00873517.

Assessment of hypokinesia in Parkinsonism.帕金森病运动迟缓的评估。

J Neural Transm. 1981;51(1-2):149-59. doi: 10.1007/BF01664012.

Assessment of extrapyramidal disorders.锥体外系疾病的评估。

Br J Clin Pharmacol. 1981 Feb;11(2):129-51. doi: 10.1111/j.1365-2125.1981.tb01118.x.

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.帕金森病患者在疾病的开期和关期的运动及认知表现。

J Neurol Neurosurg Psychiatry. 1986 Jun;49(6):657-60. doi: 10.1136/jnnp.49.6.657.

Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.帕金森病中运动幅度选择反应时间表现可能与多巴胺能状态无关。

J Neurol Neurosurg Psychiatry. 1990 Apr;53(4):279-83. doi: 10.1136/jnnp.53.4.279.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验